Paper36949880
Optimal Duration of Systemic Corticosteroids in Coronavirus Disease 2019 Treatment: A Systematic Review and Meta-analysis.
Ssentongo P and 6 others. Open Forum Infect Dis, 2023. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Optimal Duration of Systemic Corticosteroids in Coronavirus Disease 2019 Treatment: A Systematic Review and Meta-analysis. Papers, record 36949880. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36949880
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Optimal Duration of Systemic Corticosteroids in Coronavirus Disease 2019 Treatment: A Systematic Review and Meta-analysis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32345226 | Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study. | BMC Infect Dis | 2020 | https://conductscience.org/library/papers/32345226 | PubMed |
| 2 | 34824060 | Dexamethasone in hospitalised COVID-19 patients not on intensive respiratory support. | Eur Respir J | 2022 | https://conductscience.org/library/papers/34824060 | PubMed |
| 3 | 33339536 | Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study. | Crit Care | 2020 | https://conductscience.org/library/papers/33339536 | PubMed |
| 4 | 33219551 | High-dose methylprednisolone in nonintubated patients with severe COVID-19 pneumonia. | Eur J Clin Invest | 2021 | https://conductscience.org/library/papers/33219551 | PubMed |
| 5 | 32817707 | Tocilizumab and steroid treatment in patients with COVID-19 pneumonia. | PLoS One | 2020 | https://conductscience.org/library/papers/32817707 | PubMed |
| 6 | 10877304 | Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. | Biometrics | 2000 | https://conductscience.org/library/papers/10877304 | PubMed |
| 7 | 25413154 | PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. | BMC Health Serv Res | 2014 | https://conductscience.org/library/papers/25413154 | PubMed |
| 8 | 32767349 | Corticosteroid therapy for patients with severe novel Coronavirus disease 2019. | Eur Rev Med Pharmacol Sci | 2020 | https://conductscience.org/library/papers/32767349 | PubMed |
| 9 | 34396514 | Systemic corticosteroids for the treatment of COVID-19. | Cochrane Database Syst Rev | 2021 | https://conductscience.org/library/papers/34396514 | PubMed |
| 10 | 32634602 | Corticosteroid therapy for patients with COVID-19 pneumonia: a before-after study. | Int J Antimicrob Agents | 2020 | https://conductscience.org/library/papers/32634602 | PubMed |
| 11 | 33534047 | Methylprednisolone in adults hospitalized with COVID-19 pneumonia : An open-label randomized trial (GLUCOCOVID). | Wien Klin Wochenschr | 2021 | https://conductscience.org/library/papers/33534047 | PubMed |
| 12 | 32678530 | Dexamethasone in Hospitalized Patients with Covid-19. | N Engl J Med | 2021 | https://conductscience.org/library/papers/32678530 | PubMed |
| 13 | 26633262 | Corticosteroids for treating sepsis. | Cochrane Database Syst Rev | 2015 | https://conductscience.org/library/papers/26633262 | PubMed |
| 14 | 32971254 | Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study. | Clin Microbiol Infect | 2021 | https://conductscience.org/library/papers/32971254 | PubMed |
| 15 | 16807131 | Random-effects model for meta-analysis of clinical trials: an update. | Contemp Clin Trials | 2007 | https://conductscience.org/library/papers/16807131 | PubMed |
| 16 | 32109013 | Clinical Characteristics of Coronavirus Disease 2019 in China. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32109013 | PubMed |
| 17 | 33782057 | The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. | BMJ | 2021 | https://conductscience.org/library/papers/33782057 | PubMed |
| 18 | 33365358 | Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study. | Open Forum Infect Dis | 2020 | https://conductscience.org/library/papers/33365358 | PubMed |
| 19 | 32772069 | Clinical Outcomes Associated With Methylprednisolone in Mechanically Ventilated Patients With COVID-19. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/32772069 | PubMed |
| 20 | 32171076 | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. | Lancet | 2020 | https://conductscience.org/library/papers/32171076 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41805702 | Glucocorticoids suppress early lung inflammation and impair control of SARS-CoV-2 in non-human primates. | PLoS One | 2026 | https://conductscience.org/library/papers/41805702 | PubMed |
| 41782074 | The role of corticosteroids in severe viral pneumonia: lessons from COVID-19 and influenza. | Pneumonia (Nathan) | 2026 | https://conductscience.org/library/papers/41782074 | PubMed |
| 40425192 | Association of Extended Steroid Treatment With Bloodstream Infection in Critically Ill Patients With COVID-19: A National, Multicenter, Propensity Score-Matched Study. | J Korean Med Sci | 2025 | https://conductscience.org/library/papers/40425192 | PubMed |
| 40340604 | The clinical impact of prolonged steroid therapy in severe COVID-19 patients: a retrospective cohort study with propensity score matching. | BMC Pulm Med | 2025 | https://conductscience.org/library/papers/40340604 | PubMed |
| 40005350 | Should the Start of Immunosuppressive Treatment for COVID-19 Rely upon the Degree of Inflammation or the Time from Onset? | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/40005350 | PubMed |
| 39186112 | Clinical phenotyping uncovers heterogeneous associations between corticosteroid treatment and survival in critically ill COVID-19 patients. | Intensive Care Med | 2024 | https://conductscience.org/library/papers/39186112 | PubMed |
| 37892134 | Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses. | Biomolecules | 2023 | https://conductscience.org/library/papers/37892134 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36949880
GET https://conductscience.org/api/papers/v1/36949880/references?page=2